This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked SCO2 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-SCO2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~29.8 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Adrenal gland (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | — | |
| Caveat | — | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The A02749 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | HL60 cell lysate lysate (catalog A02749) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A02749 · (A) 1 and (B) 2 μg/mL (catalog A02749) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
SCO2 has a predicted monomer mass of 29.8 kDa; homodimer formation may affect migration, but no empirical band size or demonstrated shift is supplied.
| Band near 29.8 kDa | Consistent with the predicted SCO2 monomer; confirm identity with antibody controls. |
| Band near 60 kDa | Could reflect a homodimer if the complex survives sample preparation. |
| Faint or absent band in whole-cell lysate | SCO2 is an inner mitochondrial membrane protein and may be poorly recovered. |
| Stronger band after mitochondrial membrane enrichment | Consistent with SCO2 localization to the mitochondrial inner membrane. |
| Predicted monomer mass | Places the sequence-based reference near 29.8 kDa. |
| Homodimer formation | Could produce a band near twice the monomer mass if the dimer persists during electrophoresis. |
| Intrachain disulfide between residues 133 and 137 | May affect migration under different reduction conditions; no size shift is established. |
| Mitochondrial inner membrane localization | Can affect protein recovery, but does not establish a different molecular size. |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Inner mitochondrial membrane SCO2 may be poorly recovered. | Check membrane extraction and test a mitochondrial membrane-enriched fraction. |
| Band higher than expected | A SCO2 homodimer may persist during sample preparation. | Compare reducing and non-reducing preparations and verify band identity. |
| Band lower than expected | The band identity or protein integrity is uncertain. | Check antibody specificity and compare with a fresh sample. |
| Multiple bands | Monomer and persistent homodimer are possible, but identity is unconfirmed. | Compare reduction conditions and use an independent SCO2 antibody. |
| Weak or no signal | Recovery or detection of inner membrane SCO2 may be limited. | Check membrane enrichment, protein loading, and antibody performance. |
| Fragments below expected size | Protein degradation is possible; no fragment sizes are supplied. | Prepare fresh lysate with protease inhibitors and verify band identity. |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adrenal gland | glandular cells | High | Protein (IHC) | HPA → |
| Duodenum | glandular cells | High | Protein (IHC) | HPA → |
| Small intestine | glandular cells | High | Protein (IHC) | HPA → |
| Stomach | glandular cells | High | Protein (IHC) | HPA → |
| Testis | Leydig cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Liver | cholangiocytes | Not detected | Protein (IHC) | HPA → |
| Ovary | ovarian stroma cells | Not detected | Protein (IHC) | HPA → |
| Parathyroid gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Skeletal muscle | myocytes | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for SCO2, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Two human-reactive anti-SCO2 antibodies have WB images: A02749 in HL60 lysate at 1 and 2 μg/mL, and A02749-1 in 293T, HepG2, HeLa, and PC-3 lysates at 0.5 μg/mL. Evidence is limited to these reported WB contexts.
Which to pick: Choose A02749 for an HL60 WB example, or A02749-1 for its four human cell lysate examples and detailed conditions. Both have WB images; the captions do not establish performance beyond the reported samples.